We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.63B
AUM Growth
-$156M
Cap. Flow
-$162M
Cap. Flow %
-9.89%
Top 10 Hldgs %
31.09%
Holding
143
New
4
Increased
33
Reduced
15
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 31.3%
2 Technology 24.56%
3 Consumer Discretionary 12.61%
4 Industrials 7.43%
5 Utilities 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HASI icon
51
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$11M 0.67%
507,667
+142,667
+39% +$2.87M
ACAD icon
52
Acadia Pharmaceuticals
ACAD
$4.55B
$10.9M 0.66%
334,700
CSIQ icon
53
Canadian Solar
CSIQ
$1B
$9.07M 0.56%
600,000
MDVN
54
DELISTED
MEDIVATION, INC.
MDVN
$9.04M 0.55%
150,000
-334,100
-69% -$18.9M
TSLA icon
55
Tesla
TSLA
$1.22T
$8.49M 0.52%
600,000
-1,054,500
-64% -$16M
AYR
56
DELISTED
Aircastle Ltd
AYR
$8.38M 0.51%
428,600
DBVT
57
DBV Technologies
DBVT
$817M
$8.14M 0.5%
24,960
WVE icon
58
Wave Life Sciences
WVE
$1.11B
$7.86M 0.48%
+380,000
New +$5.92M
ONCE
59
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$7.67M 0.47%
150,000
TSRO
60
DELISTED
TESARO, Inc.
TSRO
$7.57M 0.46%
90,000
-90,000
-50% -$4.01M
KITE
61
DELISTED
Kite Pharma, Inc.
KITE
$7.43M 0.45%
148,600
EPIX
62
DELISTED
ESSA Pharma
EPIX
$7.37M 0.45%
135,971
UFS
63
DELISTED
DOMTAR CORPORATION (New)
UFS
$7M 0.43%
200,000
-200,000
-50% -$7.69M
CSLT
64
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$6.77M 0.41%
1,708,600
GWPH
65
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.73M 0.41%
73,500
XNCR icon
66
Xencor
XNCR
$1.59B
$6.53M 0.4%
344,000
CERN
67
DELISTED
Cerner Corp
CERN
$6.34M 0.39%
108,200
BMRN icon
68
BioMarin Pharmaceuticals
BMRN
$11.7B
$5.83M 0.36%
75,000
STML
69
DELISTED
Stemline Therapeutics, Inc.
STML
$5.76M 0.35%
851,400
NBIX icon
70
Neurocrine Biosciences
NBIX
$18.7B
$5.68M 0.35%
125,000
BPMC
71
DELISTED
Blueprint Medicines
BPMC
$5.37M 0.33%
265,000
+18,500
+8% +$336K
MCRB icon
72
Seres Therapeutics
MCRB
$46.3M
$5.18M 0.32%
8,910
SAGE
73
DELISTED
Sage Therapeutics
SAGE
$5.12M 0.31%
170,000
ALNY icon
74
Alnylam Pharmaceuticals
ALNY
$27.4B
$4.99M 0.31%
90,000
RARE icon
75
Ultragenyx Pharmaceutical
RARE
$2.56B
$4.28M 0.26%
87,400

Similar funds

Eventide Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, Eventide Asset Management held 143 positions worth $1.63B, down 8.7% from $1.79B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management withdrew a net $162M in Q2 2016, closing 14 positions and reducing 15 holdings. Its most notable exit was Red Hat Inc, an estimated $46.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Eventide Asset Management opened a new position in Arrow Electronics worth $18.3M.

  • Eventide Asset Management's largest Q2 2016 buy was Arrow Electronics: 295,000 shares worth $18.3M.
  • Eventide Asset Management added most to First Solar in Q2 2016, an estimated $24.8M increase.
  • Eventide Asset Management's biggest Q2 2016 reduction was Palo Alto Networks, cutting an estimated $19.2M.
  • Eventide Asset Management fully exited Red Hat Inc in Q2 2016, selling an estimated $46.3M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $1.63B portfolio in Q2 2016.
  • Eventide Asset Management opened 4 new positions and closed 14 in Q2 2016.
  • Eventide Asset Management's portfolio value fell 8.7% quarter-over-quarter to $1.63B.

Based on Eventide Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.